Tenax Historical Cash Flow
| TENX Stock | USD 6.00 0.10 1.64% |
Analysis of Tenax Therapeutics cash flow over time is an excellent tool to project Tenax Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 6.5 K or Other Non Cash Items of 235.9 K as it is a great indicator of Tenax Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Tenax Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tenax Therapeutics is a good buy for the upcoming year.
Tenax |
About Tenax Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Tenax balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Tenax's non-liquid assets can be easily converted into cash.
Tenax Therapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Tenax Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Tenax Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Tenax Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics' Change In Cash is fairly stable compared to the past year. Change In Working Capital is likely to rise to about 2.4 M in 2025, whereas Free Cash Flow is likely to drop (5.6 M) in 2025.
Tenax Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Tenax Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tenax Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 1.3M | (666.3K) | (3.5M) | 7.7M | 8.8M | 9.3M | |
| Free Cash Flow | (9.3M) | (10.9M) | (12.0M) | (5.9M) | (5.3M) | (5.6M) | |
| Change In Working Capital | 102.4K | (610.1K) | (1.4M) | 1.6M | 1.8M | 2.4M | |
| Begin Period Cash Flow | 4.9M | 6.3M | 5.6M | 2.1M | 2.4M | 2.3M | |
| Other Cashflows From Financing Activities | 1.7M | 544.7K | 7.9M | 14.2M | 16.3M | 17.1M | |
| Depreciation | 114.7K | 109.0K | 113.3K | 7.6K | 6.8K | 6.5K | |
| Other Non Cash Items | 361.3K | 22.1M | 366.9K | 215.9K | 248.3K | 235.9K | |
| Capital Expenditures | 3.5K | 5.3K | 2.3K | 2.8K | 2.6K | 2.4K | |
| Total Cash From Operating Activities | (9.3M) | (10.9M) | (12.0M) | (5.9M) | (5.3M) | (5.6M) | |
| Net Income | (9.9M) | (32.5M) | (11.0M) | (7.7M) | (6.9M) | (7.3M) | |
| Total Cash From Financing Activities | 10.6M | 9.7K | 8.6M | 13.6M | 15.6M | 8.8M | |
| End Period Cash Flow | 6.3M | 5.6M | 2.1M | 9.8M | 11.3M | 7.7M | |
| Change To Account Receivables | 698.4K | (22.5K) | (980.8K) | (305.7K) | (275.1K) | (261.4K) | |
| Change To Liabilities | 729.4K | 783.1K | (535.6K) | (544.6K) | (490.1K) | (465.6K) | |
| Stock Based Compensation | 352.65 | 773.79 | 365.31 | 190.85 | 171.77 | 163.18 | |
| Change To Inventory | (883.0K) | 535.6K | 544.6K | 305.7K | 351.5K | 369.1K | |
| Total Cashflows From Investing Activities | 7.4M | (1.7K) | 20.1K | 452.6K | 520.5K | 546.5K | |
| Other Cashflows From Investing Activities | 7.4M | 1.9K | 23.6 | 457.86 | 526.54 | 500.21 | |
| Change To Netincome | 606.7K | 271.7K | 361.3K | 22.1M | 25.4M | 26.7M | |
| Investments | 23.6K | 457.9K | (2.3K) | 6.8K | 7.9K | 8.3K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.